Zingiber
officinale and Citrus limon, well known as ginger and lemon, are
two vegetals widely used in traditional medicine and the culinary
field. The juices of the two vegetals were evaluated based on their
inflammation, both in vivo and in vitro. High-performance liquid chromatography
(HPLC) was used to characterize different juices from Zingiber
officinale Roscoe and Citrus limon. After
the application of the HPLC method, different compounds were identified,
such as 6-gingerol and 6-gingediol from the ginger juice and isorhamnetin
and hesperidin from the lemon juice. In addition, the two juices and
their formulation were assessed for their anti-inflammatory activity,
in vitro by utilizing the BSA denaturation test, in vivo using the
carrageenan-induced inflammation test, and the vascular permeability
test. Important and statistically significant anti-inflammatory activities
were observed for all juices, especially the formulation. The results
of our work showed clearly that the Zingiber officinale and Citrus limon juices protect in
vivo the development of the rat paw edema, especially the formulation
F composed of the Zingiber officinale and Citrus limon juices, which shows
an anti-inflammatory activity equal to −35.95% and −44.05%
using 10 and 20 mg/kg of the dose, respectively. Our work also showed
that the formulation was the most effective tested extract since it
inhibits the vascular permeability by −37% and −44%
at the doses of 200 and 400 mg/kg, respectively, and in vitro via
the inhibition of the denaturation of BSA by giving a synergetic effect
with the highest IC50 equal to 684.61 ± 7.62 μg/mL
corresponding to the formulation F. This work aims to develop nutraceutical
preparations in the future and furnishes the support for a new investigation
into the activities of the various compounds found in Zingiber officinale Roscoe and Citrus
limon.